Biologic therapies are precision-medicine injections that target specific inflammatory pathways driving severe asthma — such as Omalizumab (anti-IgE), Mepolizumab (anti-IL-5), and Dupilumab (anti-IL-4/IL-13). They are available at Pulmovista Clinics in Delhi, where Dr. Dixit Kumar Thakur conducts full biomarker-based assessments to identify the right biologic for each patient.
